USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: VISIONGATE, INC.
City: GIG HARBOR
State: WA
Zip+4: 98335-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (253) 265-0033

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $681,193.00 4

Award List:

SBIR TOPIC 195, VIRTUAL MICROSCOPY FOR THE EARLY DETECT OF CNCR

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Alan Nelson
Award Amount: $99,979.00

Development of a Vascularized In-Vitro Model of the Tumor Microenvironment

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas Neumann
Award Amount: $188,226.00
Abstract:
DESCRIPTION (provided by applicant): The study of the tumor microenvironment promises to lead to groundbreaking strategies for the therapy of cancer. Unfortunately, progress of this research is impaired by the lack of available models that recapitulate key features of the interaction between tumor… More

Development of an organotypic in-vitro model of the blood-brain barrier

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas Neumann
Award Amount: $190,632.00
Abstract:
DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) is a tight barrier formed by microvessels and capillaries controlling the passage of nutrients, fluids, metabolic products and drugs between the blood and the brain. Imbalance of the BB B is involved in a number of major… More

Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas Neumann – 206-221-3813
Award Amount: $202,356.00
Abstract:
DESCRIPTION (provided by applicant): Disregulated angiogenesis-the growth of new blood-vessels from existing vasculature-plays a central role in more than 70 major health conditions including cancer, cardiovascular disease, and macular degeneration. More than one billion people worldwide are… More